Hakan Aksoy
Hacettepe University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hakan Aksoy.
International Journal of Clinical Practice | 2010
O. Sinan Deveci; Giray Kabakci; Sercan Okutucu; Erol Tulumen; Hakan Aksoy; E. Barış Kaya; Banu Evranos; Kudret Aytemir; Lale Tokgozoglu; Aytekin Oto
Objective: This study was designed to determine the relationship between serum uric acid level and the presence and severity of coronary artery disease (CAD).
Clinical Cardiology | 2010
Mustafa Cengiz; Sercan Okutucu; Sibel Ascioglu; Abdurrahman Şahin; Hakan Aksoy; Onur Sinan Deveci; E.B. Kaya; Kudret Aytemir; Giray Kabakci; Lale Tokgozoglu; H. Ozkutlu; Ali Oto
Increasing evidence‐based indications for the implantation of permanent pacemakers (PMs) and implantable cardioverter defibrillators (ICDs) have led to an increase in the rate of device infections. The aim of the present study was to evaluate infection frequency, clinical characteristics, risk factors, and microbiologic and therapeutic features in patients with PM/ICD infections.
International Journal of Clinical Practice | 2008
Burcu Balam Yavuz; Giray Kabakci; Hakan Aksoy; Erol Tulumen; Onur Sinan Deveci; Kudret Aytemir; Lale Tokgozoglu; H. Ozkutlu; N. Nazli; Aytekin Oto
Background: Cardiovascular disease is leading cause of mortality and morbidity in developed and developing countries. Metabolic syndrome (MS) is a risk factor for coronary artery disease (CAD). The effect of MS on angiographic severity of CAD is not well defined. The aim of this study was to examine the effect of MS on angiographic severity of CAD by using Gensini score.
Pacing and Clinical Electrophysiology | 2011
Hakan Aksoy; Sercan Okutucu; Kudret Aytemir; E.B. Kaya; Erol Tulumen; Banu Evranos; S.G. Fatihoglu; Giray Kabakci; Lale Tokgozoglu; H. Ozkutlu; Ali Oto
Background: Cardiac resynchronization therapy (CRT) improves left ventricular (LV) systolic function in heart failure (HF). However, the effects of CRT on right ventricular (RV) systolic function are not fully understood.
International Journal of Rheumatic Diseases | 2011
Ali Akdogan; E.B. Kaya; Abdurrahman Sahin; Sercan Okutucu; Edibe Yakut; Umut Kalyoncu; Hakan Aksoy; Omer Karadag; Meral Calguneri; Lale Tokgozoglu; Sedat Kiraz; I. Ertenli
Objective: The six minute walk test (6MWT) is used for the assessment of functional capacity in pulmonary and cardiovascular diseases. Left ventricular diastolic dysfunction (LVDD) is the most common cardiac abnormality in systemic sclerosis (SSc). The aim of this study was to define the effect of LVDD on 6MWT parameters in patients with SSc.
Annals of Noninvasive Electrocardiology | 2011
Erol Tulumen; Indira Khalilayeva; Kudret Aytemir; F.E.S.C. Ergun Baris Kaya; Onur Sinan Deveci; Hakan Aksoy; Uğur Kocabaş; Sercan Okutucu; Lale Tokgozoglu; Giray Kabakci; H. Ozkutlu; Ali Oto
Background: Although predictive value of heart rate recovery (HRR) has been tested in large populations, the reproducibility of HRR in treadmill exercise test has not been assessed prospectively. This prospective study examined whether HRR index has test–retest stability in the short term.
Journal of Chemotherapy | 2012
Bilge Volkan Salancı; Hakan Aksoy; Pinar Özgen Kiratli; Erol Tulumen; Nilüfer Güler; Berna Oksuzoglu; Lale Tokgozoglu; Belkis Erbas; Mehmet Alikasifoglu
Abstract The aim of this prospective clinical study is to evaluate the relationship between changes in functional cardiac parameters following anthracycline therapy and carbonyl reductase 3 (CBR3p.V244M) and glutathione S transferase Pi (GSTP1p.I105V) polymorphisms. Seventy patients with normal cardiac function and no history of cardiac disease scheduled to undergo anthracycline chemotherapy were included in the study. The patients’ cardiac function was evaluated by gated blood pool scintigraphy and echocardiography before and after chemotherapy, as well as 1 year following therapy. Gene polymorphisms were genotyped in 70 patients using TaqMan probes, validated by DNA sequencing. A deteriorating trend was observed in both systolic and diastolic parameters from GG to AA in CBR3p.V244M polymorphism. Patients with G-allele carriers of GSTP1p.I105V polymorphism were common (60%), with significantly decreased PFR compared to patiens with AA genotype. Variants of CBR3 and GSTP1 enzymes may be associated with changes in short-term functional cardiac parameters.
Angiology | 2010
Onur Sinan Deveci; Giray Kabakci; Erol Tulumen; Sercan Okutucu; Hakan Aksoy; E.B. Kaya; Uğur Canpolat; Kudret Aytemir; Lale Tokgozoglu; Ali Oto
Objective: To evaluate the relationship between microalbuminuria (MA) and the presence and extent of coronary artery disease (CAD). Methods: Four hundred and two consecutive patients were divided into 4 groups based on the presence of diabetes mellitus (DM) and MA: DM(+)/MA(+), DM(+)/MA(-), DM(-)/MA(+), and DM(-)/MA(-). Severity of CAD was assessed by the Gensini scoring system. Results: The Gensini score was 57 ± 38.2 vs 16.5 ± 19.5 (P < .001) in the DM(+)/MA(+) and DM(+)/MA(-) groups and 45 ± 39.8 vs 9.9 ± 16.6 (P < .001) in the DM(-)/MA(+) and DM(-)/MA(-) groups. Spearman correlation analysis demonstrated a positive relation between urine albumin/creatinine ratio (ACR) and extent of CAD both in the diabetic and nondiabetic patients (r = .584, P = .001; r = .545, P = .001). Microalbuminuria was found to be an independent predictor for the presence (OR for MA: 3.728; 95% CI, 1.931-7.196; P < .001) and severity of CAD (P < .001, β = .563). Conclusion: A strong relationship between MA and the severity of CAD was reported.
Annals of Noninvasive Electrocardiology | 2010
Onur Sinan Deveci; Kudret Aytemir; Sercan Okutucu; Erol Tulumen; Hakan Aksoy; E.B. Kaya; Banu Evranos; Giray Kabakci; Lale Tokgozoglu; Ali Oto; H. Ozkutlu
Objective: The aim of the study was to investigate the relationship between atrial septal aneurysms (ASAs) and cardiac arrhythmias via signal‐averaged P‐wave duration (SAPWD) and P‐wave dispersion (Pd).
Europace | 2011
Sercan Okutucu; Kudret Aytemir; Banu Evranos; Hakan Aksoy; C. Sabanov; U.N. Karakulak; E.B. Kaya; Giray Kabakci; Lale Tokgozoglu; H. Ozkutlu; Ali Oto
AIMS Heart rate (HR) recovery (HRR), defined as the rate of decline in the HR immediately following the cessation of exercise, is influenced by autonomic function. Heart rate recovery in heart failure (HF) has been shown to correlate with severity of HF. Cardiac resynchronization therapy (CRT) improves cardiac autonomic functions in HF. We aimed to evaluate the effects of CRT on cardiac autonomic function assessed by HRR. METHODS AND RESULTS Forty-eight patients [62.3 ± 10.7 years; 37 men; left ventricular (LV) ejection fraction 24.8 ± 4.1%] with HF were enrolled. A treadmill exercise testing was conducted in all patients by using a modified Naughton protocol before and 6 months after CRT. Heart rate recovery indices were calculated by subtracting first, second, and third minute HR from the maximal HR and designated as HRR1, HRR2, and HRR3, respectively. Standard echocardiography was performed before and 6 months after CRT. Left ventricular reverse remodelling (LVRM) was quantified as the percentage of decline in the LV end-systolic volume after CRT. Mean HRR1 (13.0 ± 5.9 vs. 17.9 ± 8.9 b.p.m., P = 0.001), HRR2 (20.5 ± 9.3 vs. 23.8 ± 11.3 b.p.m., P = 0.001), and HRR3 (25.7 ± 11.1 vs. 29.2 ± 12.0 b.p.m., P = 0.001) values improved 6 months after CRT. Pearsons analyses revealed a good positive correlation between LVRM and ΔHRR1 (r = 0.642, P = 0.001) and a moderate correlation between reduction LVRM and ΔHRR2 (r = 0.591, P = 0.033) and ΔHRR3 (r = 0.436, P = 0.001). CONCLUSION Cardiac resynchronization therapy favourably alters the cardiac autonomic functions. Heart rate recovery indices improved after CRT and the degree of improvement in HRR indices correlated with LVRM.